Skip to main content
PMC home page
Japanese Journal of Cancer Research : Gann logoLink to Japanese Journal of Cancer Research : Gann
. 1999 Oct;90(10):1179–1186. doi: 10.1111/j.1349-7006.1999.tb00693.x

Preoperative Clinical Radioimmunodetection of Pancreatic Cancer by 111In‐labeled Chimeric Monoclonal Antibody Nd2

Tetsuji Sawada 1,✉, Tamahiro Nishihara 1, Atsushi Yamamoto 1, Hitoshi Teraoka 1, Yoshito Yamashita 1, Terue Okamura 2, Hironobu Ochi 2, Jenny J L Ho 3, Young‐Sik Kim 3, Kosei Hirakawa 1
PMCID: PMC5926001  PMID: 10595748

Abstract

The present study was carried out with the purpose of evaluating the clinical usefulness of radioimmunodetection (RAID) with 111In‐labeled murine/human chimeric monoclonal antibody, Nd2 (c‐Nd2) in patients with pancreatic cancer. Nineteen patients suspected to have pancreatic cancer were administered intravenously 74 MBq/2 mg 111In‐labeled c‐Nd2 in 100 ml of saline containing 2% albumin over 30 min. A scintigram was obtained on the 3rd day after infusion by using single photon emission computed tomography (SPECT) imaging. Of the 14 patients finally diagnosed as having pancreatic cancer on the basis of surgical specimens or progress of disease, specific focal uptake at the site of the tumor was detected in 12 (true positive cases), representing a sensitivity of 85.7% (12/14), and liver metastasis was found in one case with metastasis. Of the 5 patients diagnosed with tumor‐forming pancreatitis (TFP), 4 patients demonstrated true negative imaging, but one patient whose tumor demonstrated interesting findings in histology and immunostaining, showed false positive imaging. Of patients investigated for human anti‐chimeric antibody (HACA) response, none showed HACA response, and no allergic reaction was seen in any of the patients administered c‐Nd2. These results suggest that RAID with 111In‐labeled c‐Nd2 is useful for differential preoperative diagnosis between invasive pancreatic cancer and TFP.

Keywords: Radioimmunodetection, Pancreatic cancer, Chimeric monoclonal antibody, Nd2

Full Text

The Full Text of this article is available as a PDF (1.7 MB).

REFERENCES

  • 1. ) Chung , Y. S. , Ho , J. J. L. , Kim , Y. S. , Tanaka , H. , Nakata , B. , Hiura , A. , Motoyoshi , H. , Satake , K. and Umeyama , K.The detection of a pancreatic cancer associated antigen in the serum of cancer patients . Cancer , 60 , 1636 – 1643 ( 1987. ). [DOI] [PubMed] [Google Scholar]
  • 2. ) Goldenberg , D. M.Imaging and therapy of gastrointestinal cancers with radiolabeled antibodies . Am. J. Gastroenterol. , 86 , 1392 – 1403 ( 1991. ). [PubMed] [Google Scholar]
  • 3. ) Winzelberg , G. G. , Grossman , S. J. , Rizk , S. , Joyce , J. M. , Hill , J. B. , Atkinson , D. P. , Sudina , K. , Anderson , K. , McElwain , D. and Jones , A. M.Indium‐111 monoclonal antibody B72.3 scintigraphy in colorectal cancer–correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response . Cancer , 69 , 1656 – 1663 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 4. ) Nabi , H. A. and Doerr , R. J.Radiolabeled monoclonal antibody imaging (immunoscintigraphy) of colorectal cancers: current status and future perspective . Am. J. Surg. , 163 , 448 – 456 ( 1992. ). [DOI] [PubMed] [Google Scholar]
  • 5. ) Ho , J. J. L. , Bi , N. , Yan , P. S. , Norton , K. A. and Kim , Y. S.Characterization of new pancreatic cancer reactive monoclonal antibodies directed against purified mucin . Cancer Res. , 51 , 372 – 380 ( 1991. ). [PubMed] [Google Scholar]
  • 6. ) Sawada , T. , Chung , Y. S. , Kondo , Y. , Sowa , M. , Umeyama , K. , Ochi , H. , Ho , J. J. L. and Kim , Y. S.Radioimmunodetection of human pancreatic cancer using 111In‐labeled monoclonal antibody Nd2 . Antib. Immunoconjug. Radiopharm. , 4 , 493 – 494 ( 1991. ). [Google Scholar]
  • 7. ) Chung , Y.‐S. , Sawada , T. , Kondo , Y. , Hirayama , K. , Inui , A. , Yamashita , Y. , Nakata , B. , Okamura , T. , Ochi , H. , Ho , J. J. L. , Kim , Y. S. and Sowa , M.Radioimmunodetection with 111In‐labeled monoclonal antibody Nd2 in patients with pancreatic cancer . Jpn. J. Cancer Res. , 88 , 427 – 434 ( 1997. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. ) Kondo , Y. , Chung , Y.‐S. , Sawada , T. , Inui , A. , Yamashita , Y. , Hirayama , K. , Nakata , B. , Ho , J. J. L. , Kim , Y. S. and Sowa , M.Intratumoral injection of an adriamycin immuno‐conjugate against human pancreatic cancer xenografts . Jpn. J. Cancer Res. , 86 , 1072 – 1079 ( 1995. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. ) Inui , A. , Chung , Y.‐S. , Sawada , T. , Kondo , Y. , Ho , J. J. L. , Kim , Y. S. and Sowa , M.Radio immunotherapy for pancreatic carcinoma using 131I‐labeled monoclonal antibody Nd2 in xenografted nude mice . Jpn. J. Cancer Res. , 87 , 977 – 984 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10. ) Yasukawa , K. , Kaneko , T. , Iba , Y. , Sawada , T. , Sowa , M. , Ho , J. J. L. , Kim , Y. S. and Chung , Y. S.Preparation of mouse‐human chimeric antibody against pancreatic cancer‐associated mucin . Int. J. Oncol. , 6 , 1047 – 1052 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 11. ) Hirayama , K. , Chung , Y. S. , Sawada , T. , Kim , Y. S. and Sowa , M.Characterization and biodistribution of a mouse/human chimeric antibody directed against pancreatic cancer mucin . Cancer , 75 ( Suppl. ), 1545 – 1553 ( 1995. ). [DOI] [PubMed] [Google Scholar]
  • 12. ) Katyal , S. , Kramer , E. L. , Noz , M. E. , McCauley , D. , Chachona , A. and Steinfield , A.Fusion of immunoscintigraphy single photon emission computed tomography (SPECT) with CT of the chest in patients with non‐small cell lung cancer . Cancer Res. , 55 ( Suppl. ), 5759s – 5763s ( 1995. ). [PubMed] [Google Scholar]
  • 13. ) Maguire , R. T. , Pascucci , V. L. , Maroli , A. N. and Gulfo , J. V.Immunoscintigraphy in patients with colorectal, ovarian, and prostate cancer–results with site specific immunocon‐jugates . Cancer , 72 , 3453 – 3462 ( 1993. ). [DOI] [PubMed] [Google Scholar]
  • 14. ) Klapdor , R. and Montz , R.Radioimmunodiagnosis of pancreatic cancer disease . Int. J. Pancreatol. , 9 , 99 – 111 ( 1991. ). [PubMed] [Google Scholar]
  • 15. ) Abdel‐Nabi , H. H. , Schwartz , A. N. , Wechter , D. G. , Higano , C. S. , Ortman‐Nabi , J. A. and Unger , M. W.Scintigraphic detection of gastric and pancreatic carcinoma with In‐111 ZCE025 monoclonal antibody . World J. Surg. , 15122 – 127 ( 1991. ). [DOI] [PubMed] [Google Scholar]
  • 16. ) Boulianne , G. L. , Hozumi , N. and Schulman , M. J.Production of functional chimeric mouse/human antibody . Nature , 312 , 643 – 646 ( 1984. ). [DOI] [PubMed] [Google Scholar]
  • 17. ) Morrison , S. L. , Johnson , M. J. , Herzenberg , L. A. and Oi , V. T.Chimeric human antibody molecules: mouse antigen‐binding domains with human constant region domains . Proc. Natl. Acad. Sci. USA , 81 , 6851 – 6855 ( 1984. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. ) Juweid , M. , Sharkey , R. M. , Markowitz , A. , Behr , T. , Swayne , L. C. , Dunn , R. , Hansen , H. J. , Shevitz , J. , Leung , S. O. , Rubin , A. D. , Herskovic , T. , Hanley , D. and Golden‐berg , D. M.Treatment of non‐Hodgkin's lymphoma with radiolabeled murine, chimeric, or humanized LL2, an anti‐CD22 monoclonal antibody . Cancer Res. , 55 ( Suppl. ), 5899s – 5907s ( 1995. ). [PubMed] [Google Scholar]
  • 19. ) Sharkey , R. M. , Goldenberg , D. M. , Vagg , R. , Pawlyk , D. , Wong , G. Y. , Siegel , J. A. , Murthy , S. , Levine , G. M. , Izon , D. , Gascon , P. , Burger , K. , Swayne , L. C. and Hansen , H. J.Phase I clinical evaluation of a new murine monoclonal antibody (Mu‐9) against colon specific antigen‐P for targeting gastrointestinal carcinomas . Cancer , 73 , 864 – 877 ( 1994. ). [DOI] [PubMed] [Google Scholar]
  • 20. ) Pimm , M. V. , Perkins , A. C. , Armitage , N. C. and Baldwin , R. W.The characteristics of blood‐borne radiolabels and the effect of anti‐mouse IgG antibodies on localization of radiolabeled monoclonal antibody to cancer patients. J . Nucl. Med. , 26 , 1011 – 1023 ( 1985. ). [PubMed] [Google Scholar]
  • 21. ) Herlyn , D. , Herlyn , M. and Steplewski , Z.Monoclonal antibodies in cell‐mediated cytotoxicity against human melanoma and colorectal carcinoma . Eur. J. Immunol. , 9 , 657 – 661 ( 1979. ). [DOI] [PubMed] [Google Scholar]
  • 22. ) Liu , A. Y. , Robinson , R. R. , Hellstrom , K. E. , Murray , E. D. , Chang , C. P. and Hellstrom , I.Chimeric mouse‐human IgG1 antibody that can mediate lysis of cancer cells . Proc. Natl. Acad. Sci. USA , 84 , 3439 – 3443 ( 1987. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. ) Pullyblank , A. M. , Guillou , P. J. and Monson , J. R. T.m17‐1A‐, c17‐1A‐ and cSF25‐mediated antibody‐dependent cell‐mediated cytotoxicity in patients with advanced cancer . Br. J. Cancer , 70 , 753 – 758 ( 1994. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. ) Velders , M. P. , Litvinov , S. V. , Warnaar , S. O. , Gorter , A. , Fleuren , G. J. , Zurawski , V. R. and Coney , L. R.New chimeric anti‐pancarcinoma monoclonal antibody with superior cytotoxicity‐mediating potency . Cancer Res. , 54 , 1753 – 1759 ( 1994. ). [PubMed] [Google Scholar]
  • 25. ) Coney , L. R. , Mezzanzanica , D. , Sanborn , D. , Casalini , P. , Colnaghi , M. I. and Zurawski , V. R. , Jr.Chimeric murine‐human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing . Cancer Res. , 54 , 2448 – 2455 ( 1994. ). [PubMed] [Google Scholar]
  • 26. ) Nishihara , T. , Chung , Y. S. , Sawada , T. , Yamashita , Y. , Ho , J. J. L. , Kim , Y. S. and Sowa , M.Biological benefit of chimeric anti‐pancreatic cancer antibody Nd2 for radioimmunotherapy . Proc. Am. Assoc. Cancer Res. , 38 , 487 ( 1997. ). [Google Scholar]
  • 27. ) Sperti , C. , Pasquali , C. , Piccoli , A. and Perdrazzoli , S.Recurrence after resection for ductal adenocarcinoma of the pancreas . World J. Surg. , 21 , 195 – 200 ( 1997. ). [DOI] [PubMed] [Google Scholar]
  • 28. ) Conlon , K. C. , Klimstra , D. S. and Brennan , M.Long‐term survival after curative resection for pancreatic ductal adenocarcinoma . Ann. Surg. , 223 , 273 – 279 ( 1996. ). [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Japanese Journal of Cancer Research : Gann are provided here courtesy of Wiley

RESOURCES